|
| Catalog ID | Percent of Cells
with Chromosome | Cytogenetic Description | Additional Information |
| GM11099 | 100 | der(X)t(X;16)(q26;q24) (100%) | Line CY2; produced by the fusion of human fibro, GM03884, 46,X,t(X;16)(q26; q24), with APRT- & HPRT- deficient mouse A9 cells; selected in alanosine-adenine medium; grown in AAT medium; retains human der(X)t(X;16) in 100% of cells |
| GM11100 | 100 | der(16)t(X;16)(q26;q24) (100%) | Line CY3; produced by the fusion of human fibro, GM03884, 46,X,t(X;16)(q26; q24), with APRT- & HPRT-deficient mouse A9 cells; selected & grown in HAT medium; retains the human der(16)t(X;16) in 100% of cells |
| GM11543 | 100 | der(16)t(16;17)(q23;q21) (100%) & other human chromosomes | Line EDA5; produced by the fusion of human lymphoblasts, 46,XY,t(16;17)(q23; q21), with TK-deficient Chinese hamster a23 cells; grown in HAT culture medium; retains human der(16)t(16;17) in 100% of cells & other human chromosomes |
| GM11936 | 100 | der(16)t(11;16)(q13;p11) (100%) | Line CF52-46-6; produced by the fusion of human fibroblast, GM03005, 46,XX,t(11;16) (q13;p11), with HPRT-deficient mouse A9 cells; grown in medium with adenine, aminopterin, and thymidine; retains human der(16)t(11;16) in 100% of cells |
| GM13159 | 100 | der(4)t(4;16)(q25;q24.2) (100%) | Line CY120; produced by the fusion of human cells, 46,XX,t(4;16)(q25;q24.2), with mouse A9 cells; grown in medium with azaserine & adenine; retains human der(4)t(4;16) in 100% of cells |
| GM13161 | 100 | der(4)t(4;16)(q35;q22.3) (100%) | Line CY170; produced by the fusion of human cells, GM02346, 46,XY,t(4;16)(q35; q22.3), with mouse A9 cells; grown in medium with alanosine & adenine; retains human der(4)t(4;16) in 100% of cells |
| GM11101 | 97 | der(10)t(10;16)(q26;q22) (97%) | Line CY5; produced by the fusion of human fibro, GM01396, 46,XY,der(10)t(10; 16)(q26;q22), with APRT- & HPRT-def mouse A9 cells; selected in alanosineadenine medium; retains human der(10) in 97% of cells; grown in AAT medium |
| GM13158 | 96 | der(10)t(10;16)(q24.3;q22.1) (96%) & 8 (64%) | Line CY6; produced by the fusion of human cells, 46,XX,t(10;16)(q24.3;q22.1), with mouse A9 cells; grown in medium with alanosine & adenine; retains human der(10)t(10;16) in 96% of cells & #8 in 64% of cells |
| GM14956 | 96 | der(6)t(6;16)(q15;q24.1) (96%), 13 (80%), & 22 (88%) | Line CY100; produced by the fusion of human lymphoblast culture, GM08352, 46,XX,t(6;16)(6pter>6q15::16q24>16qter; 16pter>16q24::6q15>6qter), with APRT deficient mouse A9 cells; retains a human der(6)t(6;16)(q15;q24.1) in 96% of the cells, and a human 13, and 22 |
| GM14969 | 96 | der(16)t(6;16)(p21.3;p13.1) (96%) & 13 (24%) | Line CY185; produced by the fusion of human fibroblast line ZEH, 46,XX,t(6;16) (p21.3;p13.1), with mouse A9 cells; culture grown in medium containing adenine and azaserine; retains human der(16)t(6;16) (p21.3;p13.11) in 96% of cells and 13 (24%) |
| GM14970 | 96 | der(16)t(8;16)(p21;p13.3) (96%) & other human chromosomes | Line CY192; produced by the fusion of human cells with APRT deficient A9 mouse cells; retains a human der(16)t(8;16)(p21;p13.3) in 96% of cells and other human chromosomes |
| GM14976 | 96 | der(16)t(11;16)(q23;p12) | Line CY165; produced by the fusion human cells, der(16)t(11;16)(q23;p12.1>.2), with APRT deficient mouse A9 cells; retains a human der(16)t(11;16)(q23;p12) in 96% of cells and other human chromosomes |
| GM14972 | 92 | der(16)t(4;16)(q31;p13.3) (92%) & other human chromosomes | Line CY14; produced by the fusion of human cells with karyotype t(4;16) (q31.1;p13.3) with A9 mouse cells; grown in medium with azaserine & adenine; retains a human der(16)t(4;16)(q31;p13.3) in 92% of cells & other human chromos |
| GM13059 | 88 | der(12)t(12;16)(q13.3;p11.2) (88%) & numerous unidentified human markers | Line ML5-12 #3; resulting from the fusion of human cells with Chinese hamster K1 cells; grown in HF12D culture medium with 5mg/l proline; retains human der (12)t(12;16)(q13.3;p11.2) in 88% of cells & numerous unident human markers |
| GM14963 | 88 | der(15)t(15;16)(q26.1;q22.1) (88%), 4 (56%), 13 (76%), & 15 (56%) | Line CY124; produced by the fusion of human fibroblast line , 46,XX,t(15;16)(q26.1;q22.1), with APRT deficient mouse A9 cells; retains a human der(15)t(15;16)(q26.1;q22.1) in 88% of cells and a human 4, 13, and 15 |
| GM14975 | 84 | del(16)(p11.2p11.2) (84%) & other human chromosomes | Line CY160; produced by the fusion of human fibroblast line, GM05875, 46,XX,del(16)(p11.2p11.2), with APRT deficient mouse A9 cells; retains a human del(16)(p11.2p11.2) in 84% of cells and other human chromosomes |
| GM11939 | 76 | der(16)t(11;16)(p11.2;p11.1) (76%) & other human chromosomes | Line 16TX2; product of the fusion of human lymphoblasts, 46,XX,t(11;16)(p11.2; p11.1), GM06316A, with HPRT-deficient mouse myeloma P3/NS-1 cells; grown without selection; retains human der(16)t(11;16) in 76% of cells and other human chromosomes |
| GM13160 | 76 | der(16)t(11;16)(p11.2;p11.2) (76%) & 4 (24%) | Line CY153; produced by the fusion of human cells, GM06316A, 46,XX,t(11;16) (p11.2;p11.2), with mouse A9 cells; grown in medium with alanosine & adenine; retains human der(16)t(11;16) in 76% of cells & #4 in 24% of cells |
| GM11102 | 72 | der(3)t(3;16)(q13.2;q13) (72%) & 10 (68%) | Line CY7; cloned; produced by the fusion of human fibro, GM02860, 46,XY,t(3;16) (q13.2;q13), with APRT- & HPRT-def mouse A9 cells; grown in AAT medium; retains human der(3)t(3;16) in 72% of cells & #10 in 68% of cells |
| GM14955 | 68 | der(16)t(12;16)(q24;p11.2) (68%) & 7 (12%) & 17 (8%) | Line CY12; produced by the fusion of human cells with karyotype t(12;16) (q24;p11.2) with A9 mouse cells; grown in medium with azaserine & adenine; retains a human der(16)t(12;16)(q24;p11.2) in 68% of cells and human #7 and #17 |